| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10817927 | Clinical Biochemistry | 2013 | 6 Pages |
Abstract
CD26 expression on CD3Â + cells was strongly increased in patients with end stage kidney disease compared to HP and remained high early postTx. The differences in sCD26 and DPPIV behavior compared to that of CD26Â +/CD3Â + postTx may reflect a regulatory response to the new immunological situation and the effects of therapy.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Simone Leicht, Maria Shipkova, Corinne Klett, Helena Gert, Eva Altrock, Jens Wilhelm, Renate Bolley, Jochen Wollmeyer, Andrea Ender, Beate Luz, Christoph Olbricht, Eberhard Wieland,